Overview

The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes Inadequately Controlled on Metformin.

Status:
Not yet recruiting

Trial end date:
2024-08-01

Target enrollment:

Participant gender:

Summary

Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of DWP16001 in Combination with Metformin in Patients With Type 2 Diabetes Mellitus who Have Inadequate Glycemic Control on Metformin Alone.

Phase:

Phase 3

Details

Lead Sponsor:

Daewoong Pharmaceutical Co. LTD.

Treatments:

Dapagliflozin